These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19671587)

  • 1. Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.
    Tong CY; Mullen JE; Wong T
    J Antimicrob Chemother; 2009 Oct; 64(4):875-7. PubMed ID: 19671587
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient.
    Guo JJ; Li QL; Shi XF; Zhang DZ; Zeng AZ; Feng T; Huang AL
    Antiviral Res; 2009 Feb; 81(2):180-3. PubMed ID: 18948142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
    Liu L; Tang YZ; Li JG; Zhou JJ; Wang XH; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):423-7. PubMed ID: 20587311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B].
    Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2010 Jan; 135(1-2):32-7. PubMed ID: 20024882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 6. Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China.
    Yao G
    J Antimicrob Chemother; 2007 Aug; 60(2):201-5. PubMed ID: 17556353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?
    Degertekin B; Lok AS
    J Hepatol; 2008 Jun; 48(6):892-4. PubMed ID: 18433924
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?
    Zoulim F
    Hepatology; 2006 Dec; 44(6):1404-7. PubMed ID: 17133478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-hepatitis B virus drugs].
    Minami M
    Nihon Rinsho; 2012 Apr; 70(4):609-13. PubMed ID: 22568141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
    Su CW; Wu JC; Lee SD
    Hepatology; 2008 Nov; 48(5):1726-7; author reply 1727-8. PubMed ID: 18972445
    [No Abstract]   [Full Text] [Related]  

  • 11. Entecavir.
    Opio CK; Lee WM; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Jul; 4(7):535-6. PubMed ID: 16075486
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA, Bristol-Myers Squibb issue warning on hepatitis B drug.
    AIDS Read; 2007 Oct; 17(10):478-510. PubMed ID: 17987701
    [No Abstract]   [Full Text] [Related]  

  • 13. Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.
    Suzuki F; Akuta N; Suzuki Y; Yatsuji H; Sezaki H; Arase Y; Kawamura Y; Hosaka T; Kobayashi M; Ikeda K; Kobayashi M; Watahiki S; Kumada H
    J Clin Virol; 2007 Jun; 39(2):149-52. PubMed ID: 17442615
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of drug resistance in hepatitis viruses B and C].
    Yotsuyanagi H; Koike K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():493-6. PubMed ID: 17455669
    [No Abstract]   [Full Text] [Related]  

  • 15. Entecavir to treat severe acute hepatitis B.
    De Socio GV; Mercuri A; Di Candilo F; Baldelli F
    Scand J Infect Dis; 2009; 41(9):703-4. PubMed ID: 19544224
    [No Abstract]   [Full Text] [Related]  

  • 16. Entecavir (Bristol-Myers Squibb).
    Billich A
    Curr Opin Investig Drugs; 2001 May; 2(5):617-21. PubMed ID: 11569933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common hepatitis B drug linked to HIV antiviral resistance.
    Future Microbiol; 2007 Apr; 2(2):104. PubMed ID: 17687802
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B].
    Calcagno JI; Augustovski F; Gadano A; Souto A; Yuan Y
    Acta Gastroenterol Latinoam; 2008 Dec; 38(4):260-73. PubMed ID: 19157381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entecavir results in undetectable HBV in patients restarting treatment.
    AIDS Patient Care STDS; 2007 May; 21(5):370. PubMed ID: 17549811
    [No Abstract]   [Full Text] [Related]  

  • 20. Low incidence of entecavir resistance in nucleoside-naive chronic hepatitis B patients.
    AIDS Patient Care STDS; 2007 May; 21(5):370. PubMed ID: 17546796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.